Skip to main content
. 2015 Dec 9;93(6):1224–1230. doi: 10.4269/ajtmh.15-0256

Figure 1.

Figure 1.

Kaplan–Meier curves for free time of treatment interruption with nifurtimox (A) general, (B) including the patients lost to follow-up (worst case scenario), and (C) by severity of adverse drug reactions (ADRs).